Vincerx Pharma Inc (VINC) Return on Investment ROI from the first quarter of 2025 to first quarter of 2024 and for the year 2025, average high and low, overall ranking from Mar 31 2025 to Mar 31 2024 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Vincerx Pharma Inc   (VINC)


Vincerx Pharma Inc's ROI from its first quarter of 2025 to the first quarter of 2024 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Vincerx Pharma Inc's ROI in the first quarter of 2025?
Vincerx Pharma Inc recorded a cumulative net loss of $-23 million during 12 months ending in the first quarter of 2025, resulting in a negative return on investment (ROI) of -296.91%.

Within the Healthcare sector 833 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the fourth quarter of 2024 from 4093 to 4218.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Mar 31 2025)
I. Quarter		 (Dec 31 2024)
IV. Quarter		 (Sep 30 2024)
III. Quarter		 (Jun 30 2024)
II. Quarter		 (Mar 31 2024)
I. Quarter
Y / Y Investment Change TTM -46.11 % -68.9 % -70.26 % -73.38 % -75.02 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 2 3 10 16 0
Return On Investment (TTM) -296.91 % -416.38 % -278.81 % -241.56 % -265.24 %
VINC's Overall Ranking # 4218 # 4093 # 4170 # 3605 # 3137
Seq. Investment Change TTM 5.6 % -25.5 % -16.94 % -17.53 % -39.06 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -23 -30 -27 -28 -38

VINC Company Profile >> Back to VINC Roi Comparisons >> See Annual VINC Return On Investment



Return On Investment VINC's Ranking
Within: No.
Industry # 402
Sector # 834
Overall # 4218

Return On Investment Statistics
High Average Low
0.02 %
-131.19 %
-416.38 %
(Dec 31 2020)   (Dec 31 2024)







Financial Statements
Vincerx Pharma Inc's I. Quarter Investments $ 2 Millions VINC's Balance sheet
Vincerx Pharma Inc's I. Quarter Income $ -5 Millions Quarterly VINC's Income Statement
VINC's Income by Division See VINC's Income by Division


VINC Annual Return On Investment (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021		 (Dec 31 2020)
2020
Total Investments in Millions 3 13 50 104 87
Y / Y Investment Growth -78.4 % -74.84 % -51.69 % 19.61 % -
Net Income in Millions -30 -40 -65 -39 -17
Y / Y Net Income Growth - - - - -
Annual Return On Investment -1104.04 % -318.4 % -130.39 % -37.88 % -19.16 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
VINC's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for VINC's Competitors
Subscribers only: Roi for Vincerx Pharma Inc's Suppliers
Subscribers only: Return On Investment for VINC's Customers

Other Ratios
VINC's Roa VINC's Inventory Turnover Ratio VINC's Growth Rates VINC's Dividend Statistics
VINC's Profitability Ratios VINC's Asset Turnover Ratio VINC's Dividend Growth
VINC's Roe VINC's Valuation Ratios VINC's Financial Strength Ratios VINC's Dividend Payout Ratio



Companies with similar Return On Investment at Mar 31 2025, within Healthcare Sector ROI

Date modified: 2026-08-29T17:41:27+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.